An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 31, 2005

Conditions
Warts
Interventions
DRUG

Resiquimod

Trial Locations (10)

30263

Georgia, Newnan

47904

Indiana, Lafayette

60089

Illinois, Buffalo Grove

63110

Missouri, St Louis

67207

Kansas, Wichita

72205

Arkansas, Little Rock

72703

Arkansas, Fayetteville

84041

Utah, Layton

02114

Massachusetts, Boston

05401

Vermont, Burlington

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY